Back to Trials
NCT06844045NARecruiting

Point of Care STI Testing

Icahn School of Medicine at Mount Sinai

Start Date

2/24/2026

Completion Date

12/31/2026

Summary

The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.

Eligibility Criteria

Age Range: 16 years to 24 years

Inclusion Criteria: \- Patients age 16-24 years receiving POCT or lab-based GC/CT testing Exclusion Criteria: \- Patients with known HIV or active PrEP prescriptions.

Interventions

BEHAVIORAL

Gonorrhea/chlamydia Point-of-Care Testing

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Point of Care STI Testing

Locations

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania 19104

United States